Unparalleled Deliverability
Go after the toughest coronary lesions with the breakthrough single-emitter design of Sola™, which enables exceptional crossability.
Untethered Energy
Sola™ is designed for the most challenging procedures, offering significantly more therapeutic pulses at considerably faster rates.
With Sola™, every energy pulse delivers circumferential sonic pressure to any lesion for predictable, multi-directional performance.
Coronary Pre-Clinical Evidence
Deep Calcium Fissures
Our novel coronary system has demonstrated impressive efficacy in cadaveric artery disease models, leading to compelling luminal gain through comprehensive calcium fracturing.
Omni-Directional Calcium Cracking
FastWave’s next-gen coronary platform delivers consistent and powerful 360-degree energy, resulting in multi-directional fractures for optimal vessel expansion.
Future Studies
Coronary IDE Trial
We anticipate IDE approval from FDA to begin a coronary IDE trial in early 2026. This study will evaluate the safety and efficacy of our coronary IVL system in treating patients with calcified coronary arterial disease.
